6/18/24 17:00 | 6/16/24 | AVIR | Atea Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | MA | D | | M.d | 0 | 0.00 | 0 | 33 | New | 33 | D | | | | | | | | | | | | | | |
9/16/20 18:43 | 9/15/20 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | M.d | 42 | 4.21 | 0 | 10 | | 0 | D | | | | | | | | | | | | | | |
9/16/20 18:43 | 9/15/20 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | S.d | -100 | 10.00 | 0 | -10 | -100 | 0 | D | | | | | | | | | | | | | | |
9/15/20 16:30 | 9/14/20 | IMMU | Immunomedics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Duncan Barbara Gayle | NY | D | | M.d | 42 | 16.96 | 0 | 3 | 5 | 53 | D | | | | | | | | | | | | | | |
8/20/20 16:15 | 8/17/20 | IMMU | Immunomedics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Duncan Barbara Gayle | NY | D | | M.d | 339 | 16.96 | 0 | 20 | 66 | 50 | D | | | | | | | | | | | | | | |
8/14/20 16:33 | 8/12/20 | IMMU | Immunomedics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Duncan Barbara Gayle | NY | D | | M.d | 221 | 12.93 | 0 | 17 | 128 | 30 | D | | | | | | | | | | | | | | |
3/19/18 18:42 | 3/15/18 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | M.d | 8 | 4.21 | 0 | 2 | | 0 | D | | | | | | | | | | | | | | |
3/19/18 18:42 | 3/15/18 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | S.d | -56 | 28.11 | 0 | -2 | -100 | 0 | D | | | | | | | | | | | | | | |
1/29/18 20:26 | 1/26/18 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | M.d | 17 | 4.21 | 0 | 4 | | 0 | D | | | | | | | | | | | | | | |
1/29/18 20:26 | 1/26/18 | JNCE | Jounce Therapeutics, Inc. | | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | MA | D | | S.d | -100 | 25.00 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
10/18/17 16:16 | 10/17/17 | GNMX | Aevi Genomic Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Duncan Barbara Gayle | PA | D | | P.d | 75 | 1.26 | 0 | 60 | New | 60 | D | | | | | | | | | | | | | | |
10/5/16 21:04 | 10/3/16 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | Chief Ac | S | -24 | 163.20 | 33 | 0 | 0 | 31 | D | -37 | -11 | -7 | 7 | -8 | 1 | -8 | -5 | 0 | -1 | -24 | -29 | -29 | |
7/7/16 21:03 | 7/5/16 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | Chief Ac | S | -21 | 145.11 | 33 | 0 | 0 | 31 | D | -40 | -41 | -6 | -13 | 2 | 0 | 0 | 0 | 6 | 1 | 14 | 6 | -25 | |
4/6/16 21:00 | 4/4/16 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S | -19 | 130.76 | 33 | 0 | 0 | 31 | D | -53 | -45 | -12 | 2 | 27 | 31 | 20 | 18 | 0 | -11 | -16 | -13 | -1 | -34 |
1/5/16 21:00 | 1/1/16 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 33 | 1 | 6 | 25 | D | 115 | -7 | -38 | -14 | -12 | 1 | -4 | -4 | -8 | -19 | -36 | 0 | -5 | -33 |
1/5/16 21:00 | 1/4/16 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -68 | 145.90 | 33 | 0 | -2 | 25 | D | 115 | -7 | -38 | -14 | -12 | 1 | -4 | -4 | -8 | -19 | -36 | 0 | -5 | -33 |
10/5/15 21:02 | 10/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 9 | 3.77 | 33 | 2 | 11 | 24 | D | 139 | -27 | -37 | -28 | -10 | -11 | -6 | 9 | -4 | 5 | -2 | -14 | -12 | -6 |
10/5/15 21:02 | 10/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.dm | -172 | 163.17 | 33 | -1 | -4 | 24 | D | 139 | -27 | -37 | -28 | -10 | -11 | -6 | 9 | -4 | 5 | -2 | -14 | -12 | -6 |
7/7/15 21:00 | 7/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 33 | 1 | 7 | 19 | D | 445 | -2 | 50 | -13 | -8 | -2 | -8 | -1 | -3 | 2 | 8 | -29 | -39 | -41 |
7/7/15 21:00 | 7/2/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -13 | 236.26 | 33 | 0 | 0 | 19 | D | 445 | -2 | 50 | -13 | -8 | -2 | -8 | -1 | -3 | 2 | 8 | -29 | -39 | -41 |
7/6/15 21:00 | 7/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 9 | 8.67 | 33 | 1 | 6 | 18 | D | 444 | -2 | 55 | -11 | -9 | -1 | -9 | 0 | 1 | 3 | 8 | -32 | -37 | -39 |
7/6/15 21:00 | 7/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -242 | 242.10 | 33 | -1 | -5 | 18 | D | 444 | -2 | 55 | -11 | -9 | -1 | -9 | 0 | 1 | 3 | 8 | -32 | -37 | -39 |
4/3/15 21:01 | 4/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 33 | 1 | 8 | 18 | D | 686 | -18 | 18 | 74 | 24 | -3 | 1 | -8 | -2 | 2 | -3 | -12 | -42 | -52 |
4/3/15 21:01 | 4/2/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -11 | 277.70 | 33 | 0 | 0 | 18 | D | 686 | -18 | 18 | 74 | 24 | -3 | 1 | -8 | -2 | 2 | -3 | -12 | -42 | -52 |
4/1/15 10:00 | 3/27/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S | -290 | 289.82 | 33 | -1 | -6 | 16 | D | 666 | -14 | 17 | 83 | 31 | -1 | -3 | 0 | -2 | -3 | -10 | -14 | -44 | -54 |
1/7/15 21:00 | 1/5/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S | -25 | 176.49 | 33 | 0 | -1 | 17 | D | 369 | 136 | -28 | -31 | 3 | 19 | 6 | 3 | -4 | -3 | 27 | 72 | 48 | -11 |
1/5/15 21:00 | 1/1/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.dm | 32 | 13.88 | 33 | 2 | 15 | 17 | D | 366 | 132 | -35 | -32 | 2 | 14 | 2 | 4 | -10 | -17 | 7 | 61 | 39 | -18 |
1/5/15 21:00 | 1/2/15 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -156 | 156.40 | 33 | -1 | -5 | 17 | D | 366 | 132 | -35 | -32 | 2 | 14 | 2 | 4 | -10 | -17 | 7 | 61 | 39 | -18 |
10/3/14 21:01 | 10/1/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 32 | 13.88 | 33 | 2 | 17 | 16 | D | | 227 | -27 | -4 | -16 | -18 | -5 | -2 | -5 | -7 | 6 | -36 | 13 | -31 |
10/3/14 21:01 | 10/1/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -233 | 233.12 | 33 | -1 | -6 | 16 | D | | 227 | -27 | -4 | -16 | -18 | -5 | -2 | -5 | -7 | 6 | -36 | 13 | -31 |
7/3/14 21:03 | 7/1/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 33 | 1 | 10 | 15 | D | | 456 | 261 | -26 | 13 | -12 | -10 | 2 | -3 | -9 | -7 | -6 | -36 | -2 |
4/15/14 21:01 | 4/14/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 25 | 21.50 | 33 | 1 | 9 | 14 | D | | 668 | 327 | -30 | -41 | -27 | -20 | -15 | -5 | 13 | 9 | -11 | -22 | 9 |
4/15/14 21:01 | 4/14/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -322 | 279.00 | 33 | -1 | -8 | 14 | D | | 668 | 327 | -30 | -41 | -27 | -20 | -15 | -5 | 13 | 9 | -11 | -22 | 9 |
4/3/14 21:00 | 4/1/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 33 | 1 | 12 | 12 | D | | 856 | 330 | 384 | -12 | -26 | -10 | 4 | -10 | -7 | -18 | -23 | -28 | -15 |
1/17/14 21:01 | 1/15/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 179 | 31.90 | 33 | 6 | 111 | 11 | D | | 724 | 449 | 362 | 390 | 319 | 290 | -24 | 11 | 0 | 26 | -19 | -27 | -52 |
1/17/14 21:01 | 1/15/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -1,458 | 259.19 | 33 | -6 | -34 | 11 | D | | 724 | 449 | 362 | 390 | 319 | 290 | -24 | 11 | 0 | 26 | -19 | -27 | -52 |
1/3/14 21:01 | 1/1/14 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 15 | 1 | 14 | 11 | D | | 101 | 57 | -5 | 35 | 17 | 9 | 4 | -2 | 301 | 316 | 367 | 256 | 131 |
10/3/13 21:30 | 10/1/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 9 | 1 | 16 | 9 | D | | | 110 | 64 | 63 | 46 | 12 | 5 | 0 | -13 | -20 | 0 | 351 | 231 |
7/10/13 21:33 | 7/8/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 246 | 9.82 | 7 | 25 | | 8 | D | | | 44 | 41 | 42 | 48 | 10 | 11 | 5 | -1 | -7 | 40 | 44 | 363 |
7/10/13 21:33 | 7/8/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -1,135 | 45.39 | 7 | -25 | -76 | 8 | D | | | 44 | 41 | 42 | 48 | 10 | 11 | 5 | -1 | -7 | 40 | 44 | 363 |
7/3/13 21:35 | 7/1/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 6 | 1 | 19 | 8 | D | | | 29 | 28 | 29 | 42 | 13 | 0 | 2 | 13 | 5 | 74 | 55 | 457 |
6/21/13 21:30 | 6/19/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 487 | 9.63 | 3 | 51 | | 7 | D | | | 14 | 4 | 25 | 16 | 22 | 18 | 0 | 14 | 25 | 45 | 47 | 604 |
6/21/13 21:30 | 6/19/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -1,745 | 34.50 | 3 | -51 | -88 | 7 | D | | | 14 | 4 | 25 | 16 | 22 | 18 | 0 | 14 | 25 | 45 | 47 | 604 |
5/28/13 21:30 | 5/23/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.dm | 54 | 8.67 | 1 | 6 | 999% | 7 | D | | | 64 | -7 | 3 | 4 | 10 | 0 | 0 | -9 | 15 | 27 | 51 | 598 |
5/28/13 21:30 | 5/23/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.dm | -215 | 34.50 | 1 | -6 | -48 | 7 | D | | | 64 | -7 | 3 | 4 | 10 | 0 | 0 | -9 | 15 | 27 | 51 | 598 |
5/22/13 21:30 | 5/20/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 300 | 10.64 | 1 | 28 | | 7 | D | | | 60 | -6 | -1 | 4 | 10 | 8 | 4 | 4 | 17 | 34 | 48 | 537 |
5/22/13 21:30 | 5/20/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | S.d | -973 | 34.50 | 1 | -28 | -81 | 7 | D | | | 60 | -6 | -1 | 4 | 10 | 8 | 4 | 4 | 17 | 34 | 48 | 537 |
4/11/13 21:36 | 4/9/13 | ICPT | Intercept Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Duncan Barbara Gayle | NY | O | CFO | M.d | 0 | 0.00 | 1 | 6 | | 4 | D | | | | 4 | -10 | -7 | -5 | -2 | -2 | -9 | -10 | 43 | 86 | 757 |